Cilastatin sodium

This classification denotes a protease inhibitor with the molecular formula C16H24N2O5S.H+.Na, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 5428WXZ74M, chemically known as 2-heptenoic acid, 7-((2-amino-2-carboxyethyl)thio)-2-(((2,2-dimethylcyclopropyl)carbonyl)amino)-, monosodium salt, (r-(r*,s*-(z)))- but more generally known as cilastatin sodium, which bears US NIH Compound Identifier 5282480. European Medicines Agency schedules Cilastatin sodium in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB01295MIG. Most nations schedule cilastatin sodium under HS 29309016. SMILES:. As of Q4 2014, CILASTATIN SODIUM remains the US FDA Preferred Term for this commodity. . Cilastatin sodium bears US NLM identifiers UMLS ID C0282395 and NCI Concept Code C65329.